OSTIOZOLE

Main information

  • Trade name:
  • OSTIOZOLE 4mg Lyophilized Powder for IV Infusion
  • Dosage:
  • 4mg
  • Pharmaceutical form:
  • Lyophilized Powder for IV Infusion
  • Units in package:
  • 5ml USP Type I Flint Glass Tubular Vial with Pink Polypropylene Flip Off
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Getwell Pharmaceuticals

Documents

Localization

  • Available in:
  • OSTIOZOLE 4mg Lyophilized Powder for IV Infusion
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-5129-03
  • Authorization date:
  • 20-02-2019
  • Last update:
  • 16-01-2018